Echo Therapeutics (ECTE) Announces Common Offering

Go back to Echo Therapeutics (ECTE) Announces Common Offering

Echo Therapeutics (ECTE) Closes 3.2M Offering at 95c/Share

December 27, 2012 4:16 PM EST

Echo Therapeutics, Inc. (Nasdaq: ECTE) announced the closing of a previously announced underwritten public offering of 3,200,000 shares of its common stock and the fully exercised over-allotment option to purchase 480,000 additional shares, offered at a price of $0.95 per share. The gross proceeds to Echo from this offering... More

Echo Therapeutics (ECTE) Underwriters Exercise Full Overallotment in 3.2M Offering

December 26, 2012 4:19 PM EST

Echo Therapeutics, Inc. (Nasdaq: ECTE) announced the full exercise of the over-allotment option granted to the underwriters to purchase 480,000 additional common shares, at a public offering price of $0.95 per share, in connection with its previously announced underwritten public offering of 3,200,000 shares of common stock,... More

Echo Therapeutics (ECTE) Prices 3.2M Offering at 95c/Share

December 21, 2012 7:06 AM EST

Echo Therapeutics, Inc. (Nasdaq: ECTE) today announced the pricing of a previously announced underwritten public offering of 3,200,000 shares of its common stock, offered at a price to the public of $0.95 per share. The gross proceeds to Echo from this offering are expected to be approximately $3.0... More